Clonotypic IgM transcripts are detectable among purified sIgM plus B cells from the peripheral blood of patients with multiple myeloma.

被引：0
|
作者：
Ye, M [1 ]
Taylor, BJ [1 ]
Keats, JK [1 ]
Belch, AR [1 ]
Pilarski, LM [1 ]
机构：
[1] Univ Alberta, Edmonton, AB T6G 2M7, Canada
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5214
引用
收藏
页码：371B / 372B
页数：2
相关论文
共 50 条
  • [31] Quantitation of clonotypic B-cells in multiple myeloma (MM) patients prior to autologous peripheral blood stem cell transplantation (APBSCT) correlates with outcome of MM patients after APBSCT
    Dimitrov, R
    Novoa-Takara, L
    Vesole, DH
    Buchbinder, D
    Chang, CC
    MODERN PATHOLOGY, 2003, 16 (01) : 229A - 230A
  • [32] In multiple myeloma, clonal cells are unevenly distributed among peripheral blood B cell subpopulations.
    Papadhimitriou, SI
    Gligori, L
    Kritikou-Griva, E
    Gortzolidis, G
    Davea, A
    Paterakis, GS
    Goumakou, E
    Savvidou, I
    Grigoraki, V
    Anagnostopoulos, NI
    Georgiakaki, M
    BLOOD, 2004, 104 (11) : 399A - 399A
  • [33] Detection of pre- and post-switch clonal B cells in peripheral blood and in purified hematopioetic progenitor cell populations from multiple myeloma patients.
    Szczepek, AJ
    Belch, AR
    Mant, MJ
    Pilarski, LM
    BLOOD, 1998, 92 (10) : 271B - 271B
  • [34] Successful mobilization of peripheral blood progenitor cells with ifosfamide, epirubicin and granulocyte colony-stimulating factor in patients with multiple myeloma.
    Arland, M
    Leuner, S
    Lange, S
    Kahl, C
    Müller, G
    Jentsch-Ullrich, K
    Fostitsch, HP
    Wieker, K
    Florshütz, A
    Franke, A
    Höffkes, HG
    BONE MARROW TRANSPLANTATION, 1999, 23 : S212 - S212
  • [35] Transplantation of peripheral blood stem cells mobilized by single dose application of pegylated G-CSF in patients with multiple myeloma.
    Steidl, U
    Fenk, R
    Kondakci, M
    Henze, L
    Hoyer, B
    Graef, T
    Neumann, F
    Knipp, S
    Bork, S
    Kronenwett, R
    Gattermann, N
    Haas, R
    Kobbe, G
    BLOOD, 2003, 102 (11) : 954A - 954A
  • [36] A randomized trial of cyclophosphamide, etoposide and filgrastim with or without oprelvekin for mobilization of peripheral blood stem cells in patients with lymphoma and multiple myeloma.
    Birch, R
    Wilson-Relyea, B
    Sysel, IA
    Schwartzberg, LS
    Hazelton, B
    BLOOD, 2001, 98 (11) : 328B - 329B
  • [37] Deep Sequencing Reveals Myeloma Cells in Peripheral Blood in Majority of Multiple Myeloma Patients
    Vij, Ravi
    Mazumder, Amitabha
    Klinger, Mark
    O'Dea, Denise
    Paasch, Jacob
    Martin, Thomas
    Weng, Li
    Park, Jeesun
    Fiala, Mark
    Faham, Malek
    Wolf, Jeffrey
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (02): : 131 - 139
  • [38] Quantitation of clonotypic B-cells in multiple myeloma (MM) patients prior to autologous peripheral blood stem cell transplantation (APBSCT) correlates with outcome of MM patients after APBSCT.
    Chang, CC
    Dimitrov, R
    Novoa-Takara, L
    Woodliff, J
    Logan, B
    Vesole, DH
    BLOOD, 2002, 100 (11) : 434A - 435A
  • [39] High dose chemotherapy and peripheral blood stem cell transplant without the use of blood products in patients with multiple myeloma.
    Ford, PA
    Gottshall, E
    Matthews, BA
    Henry, DH
    BLOOD, 2000, 96 (11) : 420A - 420A
  • [40] Detection of clonotypic B cells with individual immunoglobulin ligands reveals the rarity of this cellular population in patients with multiple myeloma
    Binder, M.
    Trepel, M.
    Martens, V
    Doll, C.
    Rahlff, J.
    Goesch, B.
    Loges, S.
    ONKOLOGIE, 2012, 35 : 159 - 159
12345